Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

93.28 +2.80 (+3.09%)

Streaming Delayed Price Updated: 2:07 PM EDT, Jun 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

3 Monster Stocks to Hold for the Next 10 Years ↗

June 23, 2026

These healthcare stocks may be the building blocks of a winning portfolio.

Via The Motley Fool

Topics Intellectual Property

Should You Buy Abbott Labs Stock Hand Over Fist Before July 16? ↗

June 20, 2026

July earnings matter, but long-term growth matters more.

Via The Motley Fool

3 High-Yield Dividend Stocks to Buy Hand Over Fist in June ↗

June 15, 2026

Now's the time to load up on these high-yielders.

Via The Motley Fool

Topics Economy

Abbott Laboratories (NYSE:ABT) Presents a Decent Value Opportunity After 21% Pullback ↗

May 08, 2026

Via Chartmill

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months ↗

June 13, 2026

Analysts remain relatively more upbeat, but this could prove fleeting.

Via The Motley Fool

New Investors: 3 Rock-Solid Stocks to Build Your Portfolio Around ↗

June 09, 2026

Visa, Home Depot, and Abbott Laboratories are blue chip stocks that can provide your portfolio with a good mix of safety, stability, and dividend income over the long term.

Via The Motley Fool

Topics Credit Cards Economy

Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis? ↗

June 08, 2026

Declining sales of plant-based meats have the company looking for other revenue sources.

Via The Motley Fool

Why Grail Could Be the Sleeper Stock Everyone's About to Notice ↗

June 08, 2026

Grail is on a quest to win in a $50 billion market.

Via The Motley Fool

Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500? ↗

June 08, 2026

For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.

Via The Motley Fool

Topics Intellectual Property Stocks

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't ↗

June 03, 2026

This particular sector may suit cautious and aggressive investors.

Via The Motley Fool

3 Beaten-Down Stocks to Buy and Hold Forever ↗

June 02, 2026

Don't wait too long to buy the dip on these stocks.

Via The Motley Fool

Topics World Trade

Top gainers and losers in the S&P500 index during Thursday's after-hours session. ↗

May 28, 2026

Via Chartmill

Stay updated with the stocks that are on the move in today's after-hours session. ↗

May 28, 2026

Via Chartmill

3 Monster Dividend Stocks to Hold for the Next 10 Years ↗

May 24, 2026

These stocks are built for the long haul. And they pay great dividends.

Via The Motley Fool

Topics Energy Intellectual Property

Opinion: AbbVie Is the Best Dividend King to Buy in an Increasingly Uncertain Market ↗

May 22, 2026

This big pharma stock checks off a lot of boxes.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

3 Stocks to Buy if You Think the Economy Is Heading for a Recession ↗

May 21, 2026

They have increased their payouts for a combined 171 years straight.

Via The Motley Fool

Topics Economy

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell ↗

May 13, 2026

See the recent insider activity surrounding Okta, Micron Technology, and Abbott Laboratories, and what these moves signal to investors.

Via MarketBeat

Topics Artificial Intelligence

This Dividend ETF May Be the Ultimate Income Investment to Put in Your Portfolio Right Now ↗

May 12, 2026

The Schwab U.S. Dividend Equity ETF checks off all the key boxes investors are likely going to want from a top dividend investment.

Via The Motley Fool

Topics ETFs

Sell in May and Go Away—Starting With These 3 Stocks ↗

May 12, 2026

Oxford Club's Marc Lichtenfeld identifies three stocks worth selling in May—DexCom, Colgate-Palmolive, and Oracle—and breaks down the risks behind each call.

Via MarketBeat

Topics Artificial Intelligence

What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk ↗

May 10, 2026

This mortgage REIT generates income by originating and managing commercial real estate loans across the United States.

Via The Motley Fool

Topics Regulatory Compliance

What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress ↗

May 10, 2026

Blackstone Mortgage Trust originates senior commercial real estate loans globally, generating income primarily from interest and dividends.

Via The Motley Fool

Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗

May 06, 2026

They have combined for 118 years of consecutive dividend increases.

Via The Motley Fool

Topics Intellectual Property

Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week Lows ↗

May 06, 2026

These stocks pay more than double the S&P 500 average and have modest valuations relative to the overall market.

Via The Motley Fool

Topics Economy Stocks

Want Reliable Dividend Income in May? These 2 Stocks Deliver ↗

May 06, 2026

These stocks check off multiple boxes for income investors.

Via The Motley Fool

Topics Economy Intellectual Property

This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy? ↗

May 03, 2026

A rare yield, Dividend King status, and a steady healthcare business may be creating one of its most interesting income setups in years.

Via The Motley Fool

1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever ↗

May 02, 2026

This company, which has raised its dividend for 54 consecutive years, is on sale.

Via The Motley Fool

AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead? ↗

April 29, 2026

Via MarketBeat

How to Pick a Healthcare Stock That Can Weather Any Market ↗

April 28, 2026

How does a nearly 3% (and growing) dividend yield sound?

Via The Motley Fool

Topics Economy World Trade

This Boring Dividend King Might Be the Safest Pick to Add to Your Portfolio

April 23, 2026

Abbott Labs is a balance of income and growth.

Via Barchart.com

Better Medical Device Stock Right Now: Abbott Laboratories vs. Dexcom ↗

April 20, 2026

They offer investors very different value propositions.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.